Novo Nordisk’s new weight-loss pill Amycretin beats Wegovy in early trial



The highly anticipated new obesity pill shows the potential for greater and faster weight loss than Wegovy.

There is a new chapter in Big Pharma’s billion-dollar war on obesity, as Novo Nordisk and Eli Lilly battle it out over the latest blockbuster drugs. 



Source link

Leave a Comment

Your email address will not be published. Required fields are marked *